Glofitamab | m-entrepreneurship.com

Product Name :
Glofitamab

Search keywords :
TCB2

drugId :
null

Target Vo:
B-lymphocyte antigen CD20

Target Vo Short Name :
CD20

Moa_Name:
Anti-CD20

First Approval Country :
Canada

First Approval Date Filter:
2023

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :
F. Hoffmann-La Roche Ag

Active Indication_Name:
Lymphoma, Large B-Cell, Diffuse

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DDX3 Antibody (YA784)
PYK2 Antibody (YA682)
RASA1 Antibody: RASA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to RASA1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts